Literature DB >> 29879712

Galangin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Mitochondrial Pathway and Phosphatidylinositol 3-Kinase/Akt Inhibition.

Dan Liu1, Pengtao You1, Yan Luo2, Min Yang3, Yanwen Liu1.   

Abstract

AIMS: The study aimed to investigate the molecular mechanism of inhibition of proliferation and apoptosis induction by galangin against MCF-7 human breast cancer cells.
METHODS: Cell Counting Kit-8 assay was used to assess cell viability and flow cytometry was used to detect cell apoptosis. The expression level of apoptosis-related proteins (cleaved-caspase-9, cleaved-caspase-8, cleaved-caspase-3, Bad, cleaved-Bid, Bcl-2, Bax, p-phosphatidylinositol 3-kinase [PI3K], and p-Akt) and cell cycle-related proteins (cyclin D3, cyclin B1, cyclin-dependent kinases CDK1, CDK2, CDK4, p21, p27, p53) were evaluated by Western blotting.
RESULTS: Galangin increased the expression of Bax and decreased the expression of Bcl-2 in a concentration-dependent manner, inhibited cell viability, and induced apoptosis. Meanwhile, the expression of cleavage of caspase-9, caspase-8, caspase-3, Bid, and Bad increased significantly while the expression of p-PI3K and p-Akt proteins decreased. In addition, the protein levels of cyclin D3, cyclin B1, CDK1, CDK2, and CDK4 were downregulated while the expression levels of p21, p27, and p53 were upregulated significantly.
CONCLUSION: Galangin could suppress the viability of MCF-7 cells and induce cell apoptosis via the mitochondrial pathway and PI3K/Akt inhibition as well as cell cycle arrest.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; Cyclin-dependent kinases; Cyclins; Galangin; MCF-7 human breast cancer cells; Mitochondrial; Phosphatidylinositol 3-kinase/Akt

Mesh:

Substances:

Year:  2018        PMID: 29879712     DOI: 10.1159/000489564

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  14 in total

1.  Synthesis and Biological Evaluation of 4'-Substituted Kaempfer-3-ols.

Authors:  Sugyeom Kim; Yu Li; Lin Lin; Peyton R Sayasith; Ariel T Tarr; Eric B Wright; Sharia Yasmin; Deborah A Lannigan; George A O'Doherty
Journal:  J Org Chem       Date:  2020-02-27       Impact factor: 4.354

Review 2.  Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.

Authors:  Shazia Sofi; Umar Mehraj; Hina Qayoom; Shariqa Aisha; Syed Mohammad Basheeruddin Asdaq; Abdullah Almilaibary; Manzoor A Mir
Journal:  Med Oncol       Date:  2022-04-29       Impact factor: 3.064

3.  Galangin: A metabolite that suppresses anti-neoplastic activities through modulation of oncogenic targets.

Authors:  Hardeep Singh Tuli; Katrin Sak; Shubham Adhikary; Ginpreet Kaur; Diwakar Aggarwal; Jagjit Kaur; Manoj Kumar; Nidarshana Chaturvedi Parashar; Gaurav Parashar; Uttam Sharma; Aklank Jain
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-14

4.  Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of MicroRNA-21 Expression.

Authors:  Yang Zou; Rong Li; Dabin Kuang; Meiling Zuo; Wenqun Li; Wei Tong; Li Jiang; Min Zhou; Yin Chen; Wencheng Gong; Lijuan Liu; Fangfang Tou
Journal:  Biomed Res Int       Date:  2020-06-11       Impact factor: 3.411

5.  Revealing the Reversal Effect of Galangal (Alpinia galanga L.) Extract Against Oxidative Stress in Metastatic Breast Cancer Cells and Normal Fibroblast Cells Intended as a Co- Chemotherapeutic and Anti-Ageing Agent.

Authors:  Faradiba Nur Ahlina; Nadzifa Nugraheni; Irfani Aura Salsabila; Sari Haryanti; Muhammad Da'i; Edy Meiyanto
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

6.  Peroxiredoxin 1 silencing inhibited the growth and promoted apoptosis of pancreatic cancer cells via targeting FOXO3 gene.

Authors:  Xianchun Sun; Lingting Kong; Bingshu Li; Yan Zhang; Haiyan Yang
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

7.  Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation.

Authors:  Cong Zhang; Cui-Lian Luo; Guan-Sheng Shang; De-Xiong Jiang; Qi Song
Journal:  Med Sci Monit       Date:  2021-12-17

Review 8.  The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer.

Authors:  Lei Ding; Jiaqi Cao; Wen Lin; Hongjian Chen; Xianhui Xiong; Hongshun Ao; Min Yu; Jie Lin; Qinghua Cui
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

9.  Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells.

Authors:  Yingbing Zhang; Jiquan Wang; Beina Hui; Wenze Sun; Bin Li; Fan Shi; Shaomin Che; Linyan Chai; Liping Song
Journal:  Int J Mol Med       Date:  2019-01-10       Impact factor: 4.101

10.  Galangin promotes cell apoptosis through suppression of H19 expression in hepatocellular carcinoma cells.

Authors:  Xiaowei Zhong; Siyi Huang; Dianfeng Liu; Ziping Jiang; Qinglong Jin; Chengshun Li; Liu Da; Qunyan Yao; Dongxu Wang
Journal:  Cancer Med       Date:  2020-06-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.